When will Diclofenac Sodium Tablet, Delayed Release be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Diclofenac Sodium Tablet, Delayed Release changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Diclofenac Sodium Tablet, Delayed Release

Brand names: Diclofenac Sodium

Category: Musculoskeletal, Rheumatology

Not specified 6

FDA status: To Be Discontinued · Last FDA update: Aug 13, 2026 · First posted: Aug 13, 2026 · 1 manufacturers, 6 listed presentations

As of Aug 13, 2026, the FDA lists Diclofenac Sodium Tablet, Delayed Release as being discontinued. Of 6 manufacturer presentations, 6 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Diclofenac Sodium Tablet, Delayed Release is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-11) NDC 0228-2550-11	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-96) NDC 0228-2550-96	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-06) NDC 0228-2550-06	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-06) NDC 0228-2551-06	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-96) NDC 0228-2551-96	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.
Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-11) NDC 0228-2551-11	Teva Pharmaceuticals USA, Inc.	Not specified	A business decision was made to discontinue manufacture of the drug.

Related medications in shortage

Other Musculoskeletal, Rheumatology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Diclofenac Sodium Tablet, Delayed Release (FDA data as of Aug 13, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Diclofenac Sodium Tablet, Delayed Release. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Diclofenac Sodium Tablet, Delayed Release.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/diclofenac-sodium-tablet-delayed-release.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).